These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26600051)

  • 21. Statin therapy in the primary and secondary prevention of coronary artery disease in patients with type 2 diabetes. A scientific review.
    Paulo S; Fernandes S; Vizinho R; Carneiro AV
    Rev Port Cardiol; 2004 Nov; 23(11):1461-82. PubMed ID: 15693698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rosuvastatin-associated adverse effects and drug-drug interactions in the clinical setting of dyslipidemia.
    Kostapanos MS; Milionis HJ; Elisaf MS
    Am J Cardiovasc Drugs; 2010; 10(1):11-28. PubMed ID: 20104931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prescription of statins to dyslipidemic patients affected by liver diseases: a subtle balance between risks and benefits.
    Anfossi G; Massucco P; Bonomo K; Trovati M
    Nutr Metab Cardiovasc Dis; 2004 Aug; 14(4):215-24. PubMed ID: 15553600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
    Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
    Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of statin treatment alone and in combination with fibrates in patients with dyslipidemia: a meta-analysis.
    Choi HD; Shin WG
    Curr Med Res Opin; 2014 Jan; 30(1):1-10. PubMed ID: 24063624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefit versus risk in statin treatment.
    Guyton JR
    Am J Cardiol; 2006 Apr; 97(8A):95C-97C. PubMed ID: 16581337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary prevention with statins and incident diabetes in hypertensive patients at high cardiovascular risk.
    Izzo R; de Simone G; Trimarco V; Giudice R; De Marco M; Di Renzo G; De Luca N; Trimarco B
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1101-6. PubMed ID: 23419735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statins: Old drugs as new therapy for liver diseases?
    Pose E; Trebicka J; Mookerjee RP; Angeli P; Ginès P
    J Hepatol; 2019 Jan; 70(1):194-202. PubMed ID: 30075229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statins for treatment of chronic liver disease.
    Marrache MK; Rockey DC
    Curr Opin Gastroenterol; 2021 May; 37(3):200-207. PubMed ID: 33654016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The safety and effectiveness of statins as treatment for HIV-dyslipidemia: the evidence so far and the future challenges.
    Ahmed MH; Al-Atta A; Hamad MA
    Expert Opin Pharmacother; 2012 Sep; 13(13):1901-9. PubMed ID: 22770622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coronary event secondary prevention with statins irrespective of LDL-cholesterol.
    Kerst LL; Mauro VF
    Ann Pharmacother; 2004 Jun; 38(6):1060-4. PubMed ID: 15121997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statins and coronary artery disease: clinical evidence and future perspective.
    Biasucci LM; Stefanelli A; Biasillo G
    Minerva Cardioangiol; 2012 Apr; 60(2):147-56. PubMed ID: 22495163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The dyslipidemia of chronic renal disease: effects of statin therapy.
    Ozsoy RC; van Leuven SI; Kastelein JJ; Arisz L; Koopman MG
    Curr Opin Lipidol; 2006 Dec; 17(6):659-66. PubMed ID: 17095911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Statins under fire: justified or not?].
    Declerck E; De Loof H; De Meyer GR
    J Pharm Belg; 2009 Dec; (4):119-30. PubMed ID: 20183988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statin use and virus-related cirrhosis: A systemic review and meta-analysis.
    Ma X; Sun D; Li C; Ying J; Yan Y
    Clin Res Hepatol Gastroenterol; 2017 Oct; 41(5):533-542. PubMed ID: 28866088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. All for Statins and Statins for All; An Update.
    Agouridis AP; Elisaf MS; Nair DR; Mikhailidis DP
    Curr Pharm Des; 2016; 22(1):18-27. PubMed ID: 26548311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statins for primary prevention of cardiovascular mortality in women: a systematic review and meta-analysis.
    Bukkapatnam RN; Gabler NB; Lewis WR
    Prev Cardiol; 2010; 13(2):84-90. PubMed ID: 20377811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statin use, intensity, and 3-year clinical outcomes among older patients with coronary artery disease.
    O'Brien EC; Wu J; Schulte PJ; Christian A; Laskey W; Bhatt DL; Peterson ED; Hernandez AF; Fonarow GC
    Am Heart J; 2016 Mar; 173():27-34. PubMed ID: 26920593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
    Bruckert E; Ferrières J
    Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction in estimated risk for coronary artery disease after use of ezetimibe with a statin.
    Sampalis JS; Bissonnette S; Habib R; Boukas S;
    Ann Pharmacother; 2007 Sep; 41(9):1345-51. PubMed ID: 17666579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.